Taro Pharmaceutical Industries Quarterly Balance Sheets Chart
Quarterly
|
Annual
Taro Pharmaceutical Industries Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2023-03-31 | 2022-09-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2005-12-31 | 2004-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 154,495,000 | 175,191,000 | 251,134,000 | 523,668,000 | 614,888,000 | 605,177,000 | 552,918,000 | 498,796,000 | 532,044,000 | 513,354,000 | 509,361,000 | 560,667,000 | 632,986,000 | 567,451,000 | 566,469,000 | 825,600 | 641,989,000 | 576,611,000 | 569,193,000 | 503,321,000 | 430,713,000 | 600,399,000 | 549,646,000 | 365,638,000 | 438,732,000 | 576,757,000 | 523,214,000 | 487,695,000 | 438,998,000 | 481,641,000 | 283,219,000 | 258,615,000 | 317,873,000 | 209,967,000 | 207,455,000 | 350,611,000 | 273,558,000 | 237,284,000 | 276,995,000 | 288,135,000 | 191,247,000 | 238,266,000 | 150,001,000 | 161,510,000 | 107,703,000 | 78,872,000 | 54,157,000 | 89,477,000 | 86,309,000 | 98,439,000 | 81,704,000 | 72,862,000 | 80,755,000 | 68,828,000 | 66,253,000 | 72,828,000 | 98,630,000 |
| short-term and current maturities of long-term bank deposits | 119,980,000 | 35,573,000 | 174,158,000 | 296,188,000 | 419,324,000 | 556,121,000 | 806,558,000 | 782,813,000 | 555,127,000 | 540,326,000 | 532,624,000 | 648,297,000 | |||||||||||||||||||||||||||||||||||||||||||||
| marketable securities | 575,814,000 | 568,671,000 | 522,028,000 | 413,322,000 | 410,590,000 | 418,480,000 | 521,041,000 | 543,204,000 | 590,286,000 | 595,383,000 | 542,032,000 | 496,948,000 | 506,751,000 | 481,883,000 | 488,582,000 | 596,744 | 597,533,000 | 549,821,000 | 403,261,000 | 339,444,000 | 207,712,000 | 3,548,000 | 3,422,000 | 3,512,000 | 3,521,000 | 3,572,000 | 3,502,000 | 3,482,000 | 3,425,000 | 3,458,000 | 3,417,000 | 3,364,000 | 3,305,000 | 3,255,000 | 3,102,000 | 3,127,000 | 2,818,000 | 3,183,000 | 3,172,000 | 3,110,000 | 3,043,000 | 7,835,000 | 2,901,000 | 2,889,000 | 2,786,000 | 3,684,000 | 3,693,000 | 5,156,000 | 2,695,000 | ||||||||
| accounts receivable and other: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| trade | 202,260,000 | 248,495,000 | 246,972,000 | 196,671,000 | 216,833,000 | 213,539,000 | 228,825,000 | 231,670,000 | 189,301,000 | 235,221,000 | 227,327,000 | 247,500,000 | 213,514,000 | 237,945,000 | 223,791,000 | 224,007 | 209,135,000 | 206,455,000 | 197,799,000 | 201,710,000 | 185,881,000 | 203,924,000 | 251,623,000 | 249,750,000 | 289,803,000 | 238,611,000 | 279,538,000 | 247,278,000 | 196,795,000 | 222,427,000 | 225,653,000 | 178,732,000 | 103,526,000 | 138,772,000 | 127,010,000 | 127,318,000 | 116,599,000 | 119,810,000 | 134,590,000 | 130,285,000 | 120,832,000 | 102,660,000 | 83,135,000 | 81,815,000 | 76,031,000 | 78,018,000 | 76,671,000 | 72,695,000 | 62,098,000 | 52,954,000 | 124,674,000 | ||||||
| other receivables and prepaid expenses | 57,210,000 | 53,097,000 | 59,727,000 | 59,785,000 | 55,596,000 | 53,347,000 | 49,963,000 | 44,947,000 | 45,082,000 | 35,567,000 | 21,115,000 | 26,312,000 | 22,645,000 | 21,393,000 | 23,600,000 | 30,918 | 25,184,000 | 122,965,000 | 168,160,000 | 176,298,000 | 157,755,000 | 266,280,000 | 275,103,000 | 269,150,000 | 271,443,000 | 270,724,000 | 275,025,000 | 271,900,000 | 257,228,000 | 250,911,000 | 262,782,000 | 227,659,000 | 206,265,000 | 162,392,000 | 158,002,000 | 146,040,000 | 133,760,000 | 119,768,000 | 109,711,000 | 111,335,000 | 101,775,000 | 98,501,000 | 94,344,000 | 83,207,000 | 68,865,000 | 52,763,000 | 16,621,000 | ||||||||||
| inventories | 226,669,000 | 215,524,000 | 210,439,000 | 182,928,000 | 182,860,000 | 180,292,000 | 169,527,000 | 167,213,000 | 166,223,000 | 153,073,000 | 157,875,000 | 148,439,000 | 148,283,000 | 148,079,000 | 148,047,000 | 153,107 | 141,034,000 | 144,595,000 | 149,186,000 | 150,191,000 | 144,354,000 | 141,045,000 | 145,955,000 | 149,603,000 | 147,945,000 | 138,553,000 | 126,875,000 | 125,856,000 | 119,382,000 | 120,272,000 | 125,077,000 | 125,778,000 | 127,441,000 | 117,639,000 | 119,822,000 | 112,042,000 | 112,537,000 | 109,626,000 | 110,732,000 | 109,891,000 | 104,049,000 | 109,638,000 | 107,378,000 | 92,883,000 | 90,910,000 | 86,024,000 | 78,120,000 | 75,588,000 | 75,273,000 | 65,341,000 | 66,922,000 | 65,522,000 | 66,647,000 | 66,099,000 | 70,999,000 | 76,192,000 | |
| total current assets | 1,336,428,000 | 1,356,608,000 | 1,337,886,000 | 1,411,947,000 | 1,480,767,000 | 1,470,835,000 | 1,522,274,000 | 1,485,830,000 | 1,522,936,000 | 1,532,598,000 | 1,457,710,000 | 1,479,866,000 | 1,533,655,000 | 1,482,720,000 | 1,461,748,000 | 1,865,004 | 1,833,199,000 | 1,896,635,000 | 1,906,923,000 | 1,927,085,000 | 1,934,056,000 | 1,999,024,000 | 1,781,875,000 | 1,579,041,000 | 1,685,126,000 | 1,877,595,000 | 1,865,170,000 | 1,708,424,000 | 1,570,950,000 | 1,513,807,000 | 1,351,573,000 | 1,214,763,000 | 1,094,712,000 | 1,051,271,000 | 978,365,000 | 1,096,366,000 | 975,574,000 | 909,771,000 | 841,672,000 | 770,824,000 | 678,716,000 | 653,661,000 | 581,431,000 | 488,231,000 | 395,511,000 | 344,725,000 | 288,557,000 | 314,559,000 | 294,330,000 | 272,378,000 | 280,956,000 | 244,357,000 | 232,620,000 | 226,630,000 | 244,558,000 | 221,698,000 | 333,114,000 |
| long-term marketable securities | 404,896,000 | 435,189,000 | 459,639,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| property, plant and equipment | 190,139,000 | 191,489,000 | 199,692,000 | 196,632,000 | 202,031,000 | 205,508,000 | 206,296,000 | 207,923,000 | 209,228,000 | 209,961,000 | 206,692,000 | 206,727,000 | 205,654,000 | 206,242,000 | 197,896,000 | 198,097 | 194,797,000 | 193,727,000 | 190,468,000 | 187,937,000 | 183,415,000 | 180,085,000 | 173,446,000 | 171,427,000 | 164,598,000 | 159,459,000 | 153,343,000 | 151,053,000 | 152,902,000 | 153,045,000 | 153,488,000 | 154,199,000 | 154,939,000 | 151,416,000 | 150,960,000 | 145,527,000 | 144,073,000 | 145,265,000 | 145,762,000 | 146,812,000 | 147,779,000 | 150,750,000 | 152,532,000 | 154,565,000 | 159,424,000 | 161,671,000 | 163,183,000 | 171,210,000 | 172,212,000 | 180,440,000 | 185,159,000 | 182,406,000 | 183,111,000 | 186,543,000 | 196,466,000 | 269,419,000 | |
| deferred income taxes | 103,672,000 | 124,167,000 | 124,882,000 | 125,449,000 | 130,832,000 | 142,007,000 | 134,799,000 | 143,297,000 | 105,389,000 | 106,693,000 | 114,193,000 | 111,809,000 | 108,852,000 | 110,974,000 | 118,915,000 | 126,755 | 122,408,000 | 87,257,000 | 79,643,000 | 125,597,000 | 137,706,000 | 5,489,000 | 12,302,000 | 3,373,000 | 1,096,000 | 462,000 | 31,387,000 | ||||||||||||||||||||||||||||||
| goodwill | 17,231,000 | 12,718,000 | 11,820,000 | 7,277,000 | 7,277,000 | 7,265,000 | 7,217,000 | 7,232,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| other assets | 83,147,000 | 64,711,000 | 66,893,000 | 30,191,000 | 30,797,000 | 31,314,000 | 32,207,000 | 32,258,000 | 31,743,000 | 32,361,000 | 33,318,000 | 33,526,000 | 32,495,000 | 31,068,000 | 30,533,000 | 29,940 | 29,340,000 | 29,952,000 | 30,629,000 | 31,311,000 | 31,094,000 | 39,959,000 | 33,173,000 | 33,873,000 | 34,923,000 | 35,806,000 | 20,604,000 | 20,718,000 | 23,746,000 | 24,563,000 | 25,981,000 | 26,873,000 | 27,914,000 | 28,795,000 | 29,942,000 | 26,600,000 | 27,477,000 | 29,945,000 | 30,013,000 | 31,018,000 | 32,041,000 | 45,239,000 | 50,185,000 | 60,211,000 | 71,988,000 | 33,485,000 | 31,203,000 | 28,853,000 | 29,697,000 | 31,430,000 | |||||||
| total assets | 2,135,513,000 | 2,107,279,000 | 2,176,362,000 | 2,317,158,000 | 2,413,305,000 | 2,406,873,000 | 2,371,824,000 | 2,346,108,000 | 2,379,693,000 | 2,341,252,000 | 2,290,963,000 | 2,249,706,000 | 2,172,200,000 | 2,135,326,000 | 2,069,518,000 | 2,555,506 | 2,477,889,000 | 2,433,210,000 | 2,421,889,000 | 2,413,817,000 | 2,357,647,000 | 2,289,753,000 | 2,247,179,000 | 2,150,779,000 | 2,168,323,000 | 2,188,033,000 | 2,070,473,000 | 1,901,491,000 | 1,789,017,000 | 1,737,745,000 | 1,599,018,000 | 1,447,923,000 | 1,346,772,000 | 1,284,376,000 | 1,205,024,000 | 1,291,911,000 | 1,170,375,000 | 1,106,636,000 | 1,045,308,000 | 966,382,000 | 876,185,000 | 856,424,000 | 795,845,000 | 713,916,000 | 636,816,000 | 597,581,000 | 553,901,000 | 545,207,000 | 520,254,000 | 508,300,000 | 524,721,000 | 477,941,000 | 467,120,000 | 473,098,000 | 507,198,000 | 579,011,000 | 696,847,000 |
| liabilities and shareholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| trade payables | 68,484,000 | 61,356,000 | 68,232,000 | 55,228,000 | 62,066,000 | 61,166,000 | 45,409,000 | 39,967,000 | 36,302,000 | 28,858,000 | 37,035,000 | 38,409,000 | 37,210,000 | 35,060,000 | 32,500,000 | 30,207 | 26,513,000 | 25,697,000 | 23,885,000 | 19,387,000 | 23,321,000 | 29,768,000 | 20,527,000 | ||||||||||||||||||||||||||||||||||
| settlement and loss contingencies | 140,553,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| returns reserve | 55,865,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accrued income taxes | 33,011,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accrued expenses | 23,953,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| employees and payroll accruals | 23,055,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| medicaid and indirect rebates | 22,403,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other current liabilities | 18,224,000 | 313,495,000 | 363,886,000 | 558,730,000 | 667,084,000 | 615,135,000 | 538,668,000 | 547,349,000 | 560,185,000 | 193,873,000 | 177,144,000 | 171,092,000 | 152,023,000 | 181,761,000 | 186,139,000 | 172,852 | 166,116,000 | 190,059,000 | 189,688,000 | 161,814,000 | 149,989,000 | 71,840,000 | 42,481,000 | ||||||||||||||||||||||||||||||||||
| total current liabilities | 385,548,000 | 374,851,000 | 432,118,000 | 613,958,000 | 729,150,000 | 676,301,000 | 584,077,000 | 587,316,000 | 596,487,000 | 222,731,000 | 214,179,000 | 209,501,000 | 189,233,000 | 216,821,000 | 218,639,000 | 203,059 | 192,629,000 | 215,756,000 | 213,573,000 | 201,546,000 | 205,767,000 | 209,837,000 | 239,463,000 | 225,972,000 | 243,378,000 | 245,462,000 | 290,418,000 | 275,970,000 | 249,004,000 | 310,005,000 | 266,521,000 | 234,684,000 | 250,495,000 | 253,304,000 | 243,933,000 | 227,390,000 | 211,463,000 | 192,531,000 | 173,842,000 | 172,189,000 | 158,111,000 | 198,899,000 | 190,383,000 | 173,006,000 | 132,362,000 | 134,444,000 | 132,934,000 | 195,107,000 | 214,972,000 | 220,808,000 | 225,503,000 | 193,059,000 | 185,178,000 | 206,312,000 | 170,285,000 | 131,529,000 | |
| long-term liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other long-term liabilities | 19,106,000 | 32,799,000 | 5,367,000 | 3,996,000 | 4,934,000 | 5,512,000 | 4,931,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| total long-term liabilities | 19,106,000 | 32,799,000 | 8,762,000 | 23,144,000 | 34,399,000 | 171,861,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| commitments and contingent liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities | 404,654,000 | 400,999,000 | 464,917,000 | 644,050,000 | 755,249,000 | 711,416,000 | 621,251,000 | 627,363,000 | 705,555,000 | 231,493,000 | 222,359,000 | 218,400,000 | 197,355,000 | 224,204,000 | 223,999,000 | 207,717 | 197,825,000 | 222,811,000 | 218,415,000 | 206,316,000 | 211,762,000 | 215,947,000 | 244,920,000 | 231,152,000 | 248,895,000 | 250,889,000 | 295,013,000 | 285,619,000 | 259,004,000 | 320,362,000 | 276,587,000 | 244,987,000 | 260,827,000 | 263,783,000 | 255,160,000 | 249,901,000 | 243,300,000 | 215,675,000 | 197,202,000 | 205,199,000 | 191,298,000 | 233,466,000 | 224,782,000 | 210,956,000 | 177,269,000 | 177,019,000 | 175,242,000 | 247,699,000 | 264,158,000 | 270,473,000 | 296,033,000 | 266,869,000 | 268,528,000 | 301,156,000 | 342,146,000 | ||
| shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| taro shareholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ordinary shares of nis 0.0001 par value: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized at march 31, 2023 and march 31, 2022: 200,000,000 shares; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| issued at march 31, 2023 and march 31, 2022: 45,116,262 shares | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| outstanding at march 31, 2023 and march 31, 2022: 37,584,631 shares | 679,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| founders’ shares of nis 0.00001 par value: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized, issued and outstanding at march 31, 2023 and march 31, 2022: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2,600 shares | 1,000 | 1,000 | 1,000 | 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| additional paid-in capital | 262,445,000 | 262,445,000 | 262,445,000 | 261,008,000 | 253,577,000 | 163,769,000 | 184,562,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss, net of taxes | -174,996,000 | -168,965,000 | -163,037,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| treasury stock | -721,494,000 | -1,329,000 | -1,329,000 | -1,387,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7,531,631 shares | -771,406,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated earnings | 2,414,136,000 | 2,388,691,000 | 2,725,270,000 | 609,245,000 | 295,787,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| total shareholders’ equity | 1,730,859,000 | 1,711,445,000 | 2,109,759,000 | 890,961,000 | 571,063,000 | 236,865,000 | 368,120,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and shareholders’ equity | 2,135,513,000 | 2,107,279,000 | 2,176,362,000 | 2,341,252,000 | 1,737,745,000 | 1,599,018,000 | 1,447,923,000 | 1,346,772,000 | 1,284,376,000 | 1,205,024,000 | 1,291,911,000 | 1,170,375,000 | 1,106,636,000 | 1,045,308,000 | 966,382,000 | 876,185,000 | 856,424,000 | 795,845,000 | 713,916,000 | 636,816,000 | 597,581,000 | 553,901,000 | 545,207,000 | 508,300,000 | 579,011,000 | 696,847,000 | |||||||||||||||||||||||||||||||
| short-term bank deposits | 95,630,000 | 47,586,000 | 655,982,000 | 571,147,000 | 555,122,000 | 434,899,000 | 451,157,000 | 420,333,000 | 335,999,000 | 418,946,000 | 362,901,000 | 357,157,000 | 328,803,000 | 312,603,000 | 198,973,000 | 120,570,000 | 151,317,000 | 72,440,000 | 89,814,000 | 44,641,000 | 41,642,000 | 41,105,000 | 31,000,000 | 37,250,000 | 26,295,000 | 9,427,000 | 23,063,000 | 10,000,000 | |||||||||||||||||||||||||||||
| deferred taxes and other long-term liabilities | 26,148,000 | 30,092,000 | 26,099,000 | 35,115,000 | 37,174,000 | 40,047,000 | 109,068,000 | 8,180,000 | 8,899,000 | 8,122,000 | 7,383,000 | 5,360,000 | 4,658 | 5,196,000 | 7,055,000 | 4,842,000 | 4,770,000 | 5,995,000 | 6,110,000 | 5,457,000 | 5,180,000 | 5,517,000 | 5,427,000 | 4,595,000 | 5,150,000 | 5,381,000 | 4,857,000 | 4,864,000 | 4,591,000 | 5,120,000 | 5,139,000 | 6,116,000 | 6,049,000 | 6,240,000 | 6,618,000 | 7,258,000 | 11,839,000 | 10,491,000 | 11,100,000 | ||||||||||||||||||
| taro shareholders’ equity | 1,706,280,000 | 1,411,719,000 | 1,316,794,000 | 1,197,431,000 | 1,080,759,000 | 1,015,507,000 | 944,697,000 | 1,036,943,000 | 931,311,000 | 886,347,000 | 843,391,000 | 756,842,000 | 680,678,000 | 619,008,000 | 567,264,000 | 499,109,000 | |||||||||||||||||||||||||||||||||||||||||
| authorized at march 31, 2022 and march 31, 2021: 200,000,000 shares; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| issued at march 31, 2022 and march 31, 2021: 45,116,262 shares | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| outstanding at march 31, 2022 and march 31, 2021: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37,584,631 and 37,926,044 shares, respectively | 679,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized, issued and outstanding at march 31, 2022 and march 31, 2021: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7,531,631 and 7,190,218 shares, respectively | -771,406,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| taro shareholders' equity | 1,711,445,000 | 1,673,108,000 | 1,658,056,000 | 1,703,649,000 | 1,759,668,000 | 1,727,957,000 | 1,683,279,000 | 2,103,864,000 | 2,062,934,000 | 2,025,630,000 | 1,969,201,000 | 1,905,536,000 | 1,839,976,000 | 2,342,409 | 2,274,672,000 | 2,205,158,000 | 2,198,374,000 | 2,201,042,000 | 2,139,515,000 | 2,067,494,000 | 1,995,923,000 | 1,913,385,000 | 1,913,429,000 | 1,931,142,000 | 1,769,522,000 | 1,610,032,000 | 1,524,312,000 | 455,411,000 | 417,066,000 | ||||||||||||||||||||||||||||
| non-controlling interest | -8,192,000 | -9,095,000 | -9,212,000 | -9,141,000 | 5,895,000 | 5,670,000 | 5,676,000 | 5,644,000 | 5,586,000 | 5,543,000 | 5,380 | 5,392,000 | 5,241,000 | 5,100,000 | 6,459,000 | 6,370,000 | 6,312,000 | 6,336,000 | 6,242,000 | 5,999,000 | 6,002,000 | 5,938,000 | 5,840,000 | 5,701,000 | 5,664,000 | 5,637,000 | 5,505,000 | 5,186,000 | 5,086,000 | 5,167,000 | 5,067,000 | 4,764,000 | 4,614,000 | 4,715,000 | 4,341,000 | 4,209,000 | 3,950,000 | 3,799,000 | 3,851,000 | 4,136,000 | 3,496,000 | ||||||||||||||||
| liabilities and shareholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and shareholders' equity | 2,317,158,000 | 2,413,305,000 | 2,406,873,000 | 2,371,824,000 | 2,346,108,000 | 2,379,693,000 | 2,290,963,000 | 2,249,706,000 | 2,172,200,000 | 2,135,326,000 | 2,069,518,000 | 2,555,506 | 2,477,889,000 | 2,433,210,000 | 2,421,889,000 | 2,413,817,000 | 2,357,647,000 | 2,289,753,000 | 2,247,179,000 | 2,150,779,000 | 2,168,323,000 | 2,188,033,000 | 2,070,473,000 | 1,901,491,000 | 1,789,017,000 | 524,721,000 | 477,941,000 | 467,120,000 | 507,198,000 | ||||||||||||||||||||||||||||
| authorized at march 31, 2020 and march 31, 2019: 200,000,000 shares; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| issued at march 31, 2020 and march 31, 2019: 45,116,262 shares | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| outstanding at march 31, 2020 and march 31, 2019: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38,258,077 and 38,538,796 shares, respectively | 679,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized, issued and outstanding at march 31, 2020 and march 31, 2019: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term deposits and marketable securities | 417,778,000 | 291,544,000 | 304,322,000 | 260,426,000 | 335,710 | 298,145,000 | 225,639,000 | 214,226,000 | 141,887,000 | 71,376,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| corporate tax receivable | 9,476,000 | 25,969,000 | 11,259,000 | 34,628 | 44,166,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term assets held for sale | 1,083,000 | 1,015,000 | 999,000 | 1,062,000 | 1,058,000 | 1,081,000 | 1,034,000 | 1,066,000 | 64,000 | 67,000 | 72,000 | 73,000 | 73,000 | 71,000 | 69,000 | 67,000 | 69,000 | 68,000 | 66,000 | 81,000 | 441,000 | 470,000 | |||||||||||||||||||||||||||||||||||
| trade payables and other current liabilities | 201,546,000 | 205,767,000 | 209,837,000 | 239,463,000 | 225,972,000 | 243,378,000 | 245,462,000 | 290,418,000 | 275,030,000 | 309,093,000 | 265,623,000 | 223,206,000 | 238,302,000 | 241,330,000 | 231,849,000 | 215,510,000 | 199,966,000 | 162,756,000 | 161,504,000 | 147,545,000 | 187,942,000 | 147,160,000 | 104,998,000 | 103,535,000 | 104,739,000 | ||||||||||||||||||||||||||||||||
| long-term bank deposits | 70,685,000 | 258,685,000 | 366,438,000 | 283,676,000 | 115,173,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| restricted short-term bank deposits | 199,000 | 204,000 | 215,000 | 231,000 | 227,000 | 7,430,000 | 7,430,000 | 7,430,000 | 7,430,000 | 6,980,000 | 15,780,000 | 16,080,000 | 5,250,000 | 5,250,000 | 5,250,000 | 6,250,000 | 6,250,000 | 6,250,000 | 6,859,000 | ||||||||||||||||||||||||||||||||||||||
| current maturities of long-term debt | 940,000 | 925,000 | 912,000 | 898,000 | 11,478,000 | 12,193,000 | 11,974,000 | 12,084,000 | 11,880,000 | 11,497,000 | 11,330,000 | 11,086,000 | 10,685,000 | 10,566,000 | 10,957,000 | 17,073,000 | 13,167,000 | 13,947,000 | 13,597,000 | 13,310,000 | 16,838,000 | 17,005,000 | 14,728,000 | ||||||||||||||||||||||||||||||||||
| long-term debt, net of current maturities | 4,499,000 | 4,976,000 | 5,209,000 | 5,439,000 | 5,665,000 | 5,888,000 | 6,107,000 | 17,372,000 | 17,214,000 | 17,269,000 | 17,244,000 | 26,961,000 | 26,947,000 | 27,949,000 | 27,614,000 | 30,692,000 | 33,068,000 | 32,084,000 | 31,208,000 | 38,372,000 | 161,949,000 | 187,346,000 | |||||||||||||||||||||||||||||||||||
| long-term receivables and other assets | 31,356,000 | 21,296,000 | 46,330,000 | 67,976,000 | 52,088,000 | 69,207,000 | 52,894,000 | 45,757,000 | 23,418,000 | 23,251,000 | 23,227,000 | 27,929,000 | 18,733,000 | 18,672,000 | 19,972,000 | 23,131,000 | 25,881,000 | 31,696,000 | 30,974,000 | 27,856,000 | 19,527,000 | ||||||||||||||||||||||||||||||||||||
| long-term receivables | 41,419,000 | 19,984,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| trade payable and other current liabilities | 248,079,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long -term debt, net of current maturities | 4,740,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred income taxes and other long-term liabilities | 5,260,000 | 4,667,000 | 5,623,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| intangible assets and deferred costs | 15,607,000 | 19,172,000 | 23,756,000 | 60,673,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| taro shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized at march 31, 2013 and march 31, 2012: 200,000,000 shares; issued at march 31, 2013 and march 31, 2012: 45,091,562 and 44,800,007 shares, respectively outstanding at march 31, 2013 and march 31, 2012: 44,768,087 and 44,476,532 shares, respectively | 679,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized, issued and outstanding at march 31, 2013 and march 31, 2012: 2,600 shares | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income, net of taxes | 16,743,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable and other: trade | 120,239,000 | 111,130,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| assets held for sale | 71,000 | 462,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| short-term bank credit and short-term loans | 12,679,000 | 13,417,000 | 17,312,000 | 14,885,000 | 92,549,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized at december 31, 2011 and 2010: 200,000,000 shares; issued at december 31, 2011 and 2010: 44,799,507 and 43,341,732 shares, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| outstanding at december 31, 2011 and 2010: 44,476,032 and 43,018,257 shares, respectively | 679,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized, issued and outstanding at december 31, 2011 and 2010: 2,600 shares | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | 18,549,000 | 11,811,000 | 13,477,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other receivables, prepaid expenses and other | 45,556,000 | 23,820,000 | 21,837,000 | 21,226,000 | 19,605,000 | 12,865,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term investments | 30,173,000 | 25,953,000 | 22,509,000 | 23,307,000 | 29,753,000 | 21,481,000 | 19,959,000 | 20,713,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| shareholders' equity | 378,659,000 | 297,508,000 | 256,096,000 | 237,827,000 | 228,688,000 | 211,072,000 | 198,592,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| short-term bank credits | 74,851,000 | 88,771,000 | 89,935,000 | 96,792,000 | 87,285,000 | 90,292,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued expenses | 103,418,000 | 109,196,000 | 99,192,000 | 77,868,000 | 66,207,000 | 80,898,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term liabilities | 40,113,000 | 37,591,000 | 49,050,000 | 54,767,000 | 64,700,000 | 86,479,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred taxes and other liabilities | 12,479,000 | 11,595,000 | 21,480,000 | 19,043,000 | 18,650,000 | 8,365,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shareholders’ equity | 520,254,000 | 206,042,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other intangible assets and deferred charges | 21,537,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current maturities of long-term liabilities | 29,265,000 | 29,519,000 | 27,906,000 | 28,679,000 | 32,166,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable - trade | 79,252,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable - other and prepaid expenses | 23,765,000 | 17,133,000 | 14,789,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable – trade | 82,590,000 | 64,179,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| taro pharmaceutical industries ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| consolidated balance sheets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| u.s. dollars and shares in thousands | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, net – trade | 72,037,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable – other and prepaid expenses | 35,269,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred taxes and other assets | 45,461,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| short-term bank liabilities* | 93,248,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| share capital: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized at december 31, 2005: 200,000,000 shares; issued | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| at december 31, 2005: 29,566,749 shares, | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| outstanding at december 31, 2005: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29,300,865 shares | 679,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| authorized, issued and outstanding at december 31, 2005: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| retained earnings | 61,992,000 | 170,749,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other intangible assets and deferred | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| charges | 63,174,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other and accrued expenses | 31,779,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accrued severance pay and other long term liabilities | 2,442,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| minority interest | 694,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total long-term liabilities and minority | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest | 197,198,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred stock-based compensation |
We provide you with 20 years of balance sheets for Taro Pharmaceutical Industries stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Taro Pharmaceutical Industries. Explore the full financial landscape of Taro Pharmaceutical Industries stock with our expertly curated balance sheets.
The information provided in this report about Taro Pharmaceutical Industries stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.